• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m6A 调控的肿瘤糖酵解:表观遗传学和代谢领域的新进展。

m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism.

机构信息

Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Hubei Key Laboratory of Hepato‑Pancreatic‑Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Mol Cancer. 2023 Aug 15;22(1):137. doi: 10.1186/s12943-023-01841-8.

DOI:10.1186/s12943-023-01841-8
PMID:37582735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10426175/
Abstract

Glycolytic reprogramming is one of the most important features of cancer and plays an integral role in the progression of cancer. In cancer cells, changes in glucose metabolism meet the needs of self-proliferation, angiogenesis and lymphangiogenesis, metastasis, and also affect the immune escape, prognosis evaluation and therapeutic effect of cancer. The n6-methyladenosine (m6A) modification of RNA is widespread in eukaryotic cells. Dynamic and reversible m6A modifications are widely involved in the regulation of cancer stem cell renewal and differentiation, tumor therapy resistance, tumor microenvironment, tumor immune escape, and tumor metabolism. Lately, more and more evidences show that m6A modification can affect the glycolysis process of tumors in a variety of ways to regulate the biological behavior of tumors. In this review, we discussed the role of glycolysis in tumor genesis and development, and elaborated in detail the profound impact of m6A modification on different tumor by regulating glycolysis. We believe that m6A modified glycolysis has great significance and potential for tumor treatment.

摘要

糖酵解重编程是癌症的最重要特征之一,在癌症的进展中起着重要作用。在癌细胞中,葡萄糖代谢的变化满足了自我增殖、血管生成和淋巴管生成、转移的需求,还影响了癌症的免疫逃逸、预后评估和治疗效果。RNA 的 N6-甲基腺苷(m6A)修饰广泛存在于真核细胞中。动态和可逆的 m6A 修饰广泛参与调节癌症干细胞更新和分化、肿瘤治疗耐药性、肿瘤微环境、肿瘤免疫逃逸和肿瘤代谢。最近,越来越多的证据表明,m6A 修饰可以通过多种方式影响肿瘤的糖酵解过程,从而调节肿瘤的生物学行为。在这篇综述中,我们讨论了糖酵解在肿瘤发生和发展中的作用,并详细阐述了 m6A 修饰通过调节糖酵解对不同肿瘤的深刻影响。我们相信 m6A 修饰的糖酵解对肿瘤治疗具有重要意义和潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/17e3c19f9751/12943_2023_1841_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/0a95c3b0fd9c/12943_2023_1841_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/0537d2289360/12943_2023_1841_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/8d9f5cadb600/12943_2023_1841_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/17e3c19f9751/12943_2023_1841_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/0a95c3b0fd9c/12943_2023_1841_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/0537d2289360/12943_2023_1841_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/8d9f5cadb600/12943_2023_1841_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc65/10426175/17e3c19f9751/12943_2023_1841_Fig4_HTML.jpg

相似文献

1
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism.m6A 调控的肿瘤糖酵解:表观遗传学和代谢领域的新进展。
Mol Cancer. 2023 Aug 15;22(1):137. doi: 10.1186/s12943-023-01841-8.
2
Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.m6A 修饰与肿瘤微环境中非编码 RNA 的串扰。
Int J Biol Sci. 2023 Apr 17;19(7):2198-2219. doi: 10.7150/ijbs.79651. eCollection 2023.
3
Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.肿瘤微环境中非编码 RNA 的 N6-甲基腺苷(m6A)修饰的研究进展。
Aging (Albany NY). 2023 May 12;15(9):3857-3889. doi: 10.18632/aging.204679.
4
Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification.通过 N6-甲基腺苷 RNA 修饰来操纵肿瘤免疫微环境。
Cancer Gene Ther. 2024 Sep;31(9):1315-1322. doi: 10.1038/s41417-024-00791-7. Epub 2024 Jun 4.
5
Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.甲状腺癌中m6A甲基化修饰及肿瘤微环境浸润的特征分析
Clin Transl Oncol. 2023 Jan;25(1):269-282. doi: 10.1007/s12094-022-02940-6. Epub 2022 Sep 26.
6
The potential role of m6A modifications on immune cells and immunotherapy.m6A修饰在免疫细胞和免疫治疗中的潜在作用。
Biomed Pharmacother. 2023 Apr;160:114343. doi: 10.1016/j.biopha.2023.114343. Epub 2023 Feb 7.
7
RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.RNA N6-甲基腺嘌呤修饰在调控癌症干细胞和肿瘤免疫微环境中的作用及其在癌症治疗中的意义
J Cancer Res Clin Oncol. 2023 Apr;149(4):1621-1633. doi: 10.1007/s00432-022-04158-z. Epub 2022 Jul 7.
8
N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.N6-甲基腺苷(m6A)在癌症治疗耐药中的作用:潜在机制和临床意义。
Biomed Pharmacother. 2023 Nov;167:115477. doi: 10.1016/j.biopha.2023.115477. Epub 2023 Sep 9.
9
[Research Progress of m6A Methylation Modification in Hematological Tumors--Review].[六甲基腺嘌呤甲基化修饰在血液系统肿瘤中的研究进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Oct;30(5):1607-1611. doi: 10.19746/j.cnki.issn.1009-2137.2022.05.048.
10
The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.m6A 表观遗传修饰在肿瘤编码和非编码 RNA 加工中的作用。
Cell Commun Signal. 2023 Dec 15;21(1):355. doi: 10.1186/s12964-023-01385-w.

引用本文的文献

1
FTOregulated mA modification of primiR139 represses papillary thyroid carcinoma metastasis.FTO调控的初级微小RNA-139的N6-甲基腺苷修饰抑制甲状腺乳头状癌转移
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 May 28;50(5):815-826. doi: 10.11817/j.issn.1672-7347.2025.250018.
2
Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications.肿瘤发生过程中乳酸化与RNA修饰之间的相互作用:机制及治疗意义
Biomark Res. 2025 Aug 26;13(1):110. doi: 10.1186/s40364-025-00824-9.
3
Degradation of IRF6 by TRIM59 in tumor cells triggers PGM1-mediated glycolysis to regulate cell proliferation in neuroblastoma.
TRIM59在肿瘤细胞中对IRF6的降解触发了PGM1介导的糖酵解,以调节神经母细胞瘤中的细胞增殖。
Cell Death Dis. 2025 Aug 12;16(1):613. doi: 10.1038/s41419-025-07932-2.
4
Development of a prognostic model based on m6A reader upregulation and immune infiltration in multiple malignant tumors.基于m6A阅读蛋白上调和免疫浸润构建多种恶性肿瘤预后模型
Transl Cancer Res. 2025 Jul 30;14(7):4219-4242. doi: 10.21037/tcr-2024-2616. Epub 2025 Jul 27.
5
Research Progress on Glycolysis in the Pathogenesis of Asthma.哮喘发病机制中糖酵解的研究进展
J Asthma Allergy. 2025 Jul 26;18:1147-1160. doi: 10.2147/JAA.S528965. eCollection 2025.
6
Dynamic Rendition of Adipose Genes Under Epigenetic Regulation: Revealing New Mechanisms of Obesity Occurrence.表观遗传调控下脂肪基因的动态呈现:揭示肥胖发生的新机制
Curr Issues Mol Biol. 2025 Jul 11;47(7):540. doi: 10.3390/cimb47070540.
7
The Multifaceted Role of VIRMA, a Core Component of the Methyltransferase Complex, in Cancer and Cancer Therapy.VIRMA(甲基转移酶复合物的核心成分)在癌症及癌症治疗中的多方面作用
Biomolecules. 2025 Jun 22;15(7):912. doi: 10.3390/biom15070912.
8
METTL3 overexpression and ATF6 silencing-induced Inhibition in HAS2 expression relieves PDGF-BB stimulation-induced HA production and the proliferation of human orbital fibroblasts in graves' ophthalmopathy.METTL3过表达和ATF6沉默诱导的HAS2表达抑制减轻了血小板衍生生长因子-BB(PDGF-BB)刺激诱导的透明质酸(HA)产生以及格雷夫斯眼病中人类眼眶成纤维细胞的增殖。
J Endocrinol Invest. 2025 Jul 9. doi: 10.1007/s40618-025-02647-9.
9
Dauriporphine inhibited lung cancer cell viability, motility, and energy metabolism through the miR-424-5p/MAPK14 axis.大叶紫堇啡碱通过miR-424-5p/MAPK14轴抑制肺癌细胞的活力、迁移能力和能量代谢。
Hereditas. 2025 Jun 11;162(1):101. doi: 10.1186/s41065-025-00473-w.
10
N-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis.N-甲基腺苷调节的外泌体生物合成在胃癌腹膜转移中协调形成免疫抑制性的前转移微环境。
Cancer Commun (Lond). 2025 Aug;45(8):941-965. doi: 10.1002/cac2.70034. Epub 2025 May 15.